353 results on '"Minami, Masahito"'
Search Results
2. Hepatic nucleotide binding oligomerization domain‐like receptors pyrin domain‐containing 3 inflammasomes are associated with the histologic severity of non‐alcoholic fatty liver disease
3. Early Detection of Lamivudine Resistant Mutant in Chronic Hepatitis B Patients Using a Novel Sensitive Method
4. Factors Related to the Development of Hepatocellular Carcinoma from Chronic Liver Diseases Type B and C
5. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease
6. Future therapy for hepatitis B virus infection
7. Nonalcoholic steatohepatitis and increased risk of chronic kidney disease
8. PEG10 is a probable target for the amplification at 7q21 detected in hepatocellular carcinoma
9. The fatty acid composition of plasma cholesteryl esters and estimated desaturase activities in patients with nonalcoholic fatty liver disease and the effect of long-term ezetimibe therapy on these levels
10. Drug-induced liver injury in a chronic hepatitis C patient treated by peginterferon, ribavirin and simeprevir
11. Serum alanine aminotransferase predicts the histological course of non-alcoholic steatohepatitis in Japanese patients
12. Lower levels of insulin-like growth factor-1 standard deviation score are associated with histological severity of non-alcoholic fatty liver disease
13. Predictors of malignancies and overall mortality in Japanese patients with biopsy-proven non-alcoholic fatty liver disease
14. Blockade of interleukin 6 signalling ameliorates systemic insulin resistance through upregulation of glucose uptake in skeletal muscle and improves hepatic steatosis in high-fat diet fed mice
15. A novel amplification target, ARHGAP5, promotes cell spreading and migration by negatively regulating RhoA in Huh-7 hepatocellular carcinoma cells
16. Efficacy and safety of sorafenib in very elderly patients aged 80 years and older with advanced hepatocellular carcinoma
17. Dynamics of Hepatitis C Viremia following Interferon-α Administration
18. Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma
19. Efficacy of long-term ezetimibe therapy in patients with nonalcoholic fatty liver disease
20. CREB3L4, INTS3, and SNAPAP are targets for the 1q21 amplicon frequently detected in hepatocellular carcinoma
21. Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease
22. Interferon and nucleoside analog combination therapy for hepatitis B
23. Steatosis and hepatic expression of genes regulating lipid metabolism in Japanese patients infected with hepatitis C virus
24. Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
25. Circulating tumor cells in peripheral blood caused by surgical manipulation of non-small-cell lung cancer: pilot study using an immunocytology method
26. Update of research and management of hepatitis B
27. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis
28. Clinical characteristics and prevalence of GB virus C, SEN virus, and HFE gene mutation in Japanese patients with nonalcoholic steatohepatitis
29. Prediction of a favorable clinical course in hepatitis C virus carriers with persistently normal serum alanine aminotransferase levels: A long-term follow-up study
30. Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats
31. Treatment extension may benefit female genotype 1 chronic hepatitis C patients with complete early virological response to peginterferon-alpha-2b and ribavirin combination therapy
32. Factors that may enhance the prediction of non-virological response to PEG-IFN/RBV/TPV therapy by IL28B SNP (rs8099917) for genotype 1 chronic hepatitis C: 1847
33. Rosuvastatin ameliorates high fat and high cholesterol diet-induced rat nonalcoholic steatohepatitis through not only its lipid-lowering activity but also its anti-inflammatory and fibrotic effects: 1428
34. Distinctive pathogenic roles of iron deposition in hepatocytes and reticuloendothelial cells for the development of chronic hepatitis C: 1039
35. Helicobacter pylori-negative gastric and duodenal ulcers
36. Hepatic steatosis in chronic hepatitis C patients infected with genotype 2 is associated with insulin resistance, hepatic fibrosis and affects cumulative positivity of serum hepatitis C virus RNA in peginterferon and ribavirin combination therapy
37. Simple formula to predict response to peginterferon alpha2b and ribavirin combination therapy in genotype 1 chronic hepatitis C patients with high viral loads
38. VIII. Drug Development and Clinical Trial Status for NASH/NAFLD
39. Lower circulating levels of dehydroepiandrosterone, independent of insulin resistance, is an important determinant of severity of non-alcoholic steatohepatitis in Japanese patients
40. Relapse of hepatitis C in a pegylated-interferon-α-2b plus ribavirin-treated sustained virological responder
41. A follow-up study to determine the value of liver biopsy and need for antiviral therapy for hepatitis C virus carriers with persistently normal serum aminotransferase
42. Analysis of hepatic genes involved in the metabolism of fatty acids and iron in nonalcoholic fatty liver disease
43. Molecular Characterization of a Variant Virus That Caused De Novo Hepatitis B Without Elevation of Hepatitis B Surface Antigen After Chemotherapy With Rituximab
44. Activation of B-Myb by E2F1 in hepatocellular carcinoma
45. Evidence of oxidative stress as a cofactor in the development of insulin resistance in patients with chronic hepatitis C
46. Non-prescription supplement-induced hepatitis with hyperferritinemia and mutation (H63D) in the HFE gene
47. Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts
48. Low serum level of hepatitis B core-related antigen indicates unlikely reactivation of hepatitis after cessation of lamivudine therapy
49. Management of HBV infection in Japan
50. Role of cell-cycle turnover and oxidative stress in telomere shortening and cellular senescence in patients with chronic hepatitis C
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.